WorldHeart Submits IDE Application For Study Of Levacor VAD
World Heart Corporation has submitted an Investigational Device Exemption ("IDE") application to the US Food and Drug Administration…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jan 09
World Heart Corporation has submitted an Investigational Device Exemption ("IDE") application to the US Food and Drug Administration…
08 Jan 09
Studies, from the Netherlands and the United States, question the accuracy and value of the long-established Framingham Risk…
08 Jan 09
Genomic Health, Inc. (Genomic) has appointed Kimberly J. Popovits as its president and chief executive officer (CEO). Prior…
08 Jan 09
MDS Inc. (MDS) has reported total revenues of $322 million for the fourth quarter of fiscal 2008. It…
08 Jan 09
Millipore Corporation (Millipore) has appointed Jon DiVincenzo as president for its Bioscience Division and member to its corporate…
08 Jan 09
Agendia B.V. (Agendia) has appointed Kurt Schmidt as its chief financial officer (CFO). In this capacity, Schmidt replaces…
08 Jan 09
Response Genetics, Inc. (Response Genetics) announced its plan to triple the size of its sales force in response…
08 Jan 09
The Spectranetics Corporation (Spectranetics) has reported preliminary revenue of $104 million for the 2008, up 26%, compared with…
08 Jan 09
Implantable Provider Group (IPG) has appointed Pat Reynolds as its vice president of sales. Prior to joining IPG,…
08 Jan 09
Teleflex Incorporated (Teleflex) has provided full year 2009 guidance. For the period, company expects total revenues exceeding $2.4…